Good to see commissioning of Stage 2 still on target for Feb 2022 and still expect PFS this year.
Stage 2 fully funded with start-up in 6 months, NPV 1.14b, post tax NPV of $800m and we currently have a market cap of $275m
Trading at 35% of fully funded post-tax NPV and you get HPMSM for free.
IMO makes no sense why the S/P is not a lot higher.
- Forums
- ASX - By Stock
- E25
- Ann: Investor Presentation - August 2021
E25
element 25 limited
Add to My Watchlist
2.22%
!
23.0¢

Ann: Investor Presentation - August 2021, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
23.0¢ |
Change
0.005(2.22%) |
Mkt cap ! $52.58M |
Open | High | Low | Value | Volume |
21.5¢ | 23.0¢ | 21.5¢ | $51.72K | 233.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 99056 | 22.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.0¢ | 72937 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 112760 | 0.220 |
1 | 2778 | 0.215 |
3 | 15119 | 0.210 |
3 | 28107 | 0.205 |
8 | 57905 | 0.200 |
Price($) | Vol. | No. |
---|---|---|
0.230 | 18000 | 1 |
0.235 | 24800 | 2 |
0.240 | 55584 | 2 |
0.245 | 31276 | 2 |
0.250 | 20000 | 2 |
Last trade - 16.10pm 30/06/2025 (20 minute delay) ? |
Featured News
E25 (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Dr. Steven Gourlay, CEO
Dr. Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online